Phase 1 Open Angle Glaucoma Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma
Primary Open Angle Glaucoma (POAG)
IVIEW Therapeutics Inc.6 enrolled1 locationNCT06921317
Recruiting
Phase 1Phase 2
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Open Angle GlaucomaOcular Hypertension
AbbVie96 enrolled49 locationsNCT04499248
Recruiting
Phase 1
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Open Angle GlaucomaOcular Hypertension
Amneal Pharmaceuticals, LLC240 enrolled4 locationsNCT06267274
Recruiting
Phase 1
Phase I study of a Latanoprost Ocular Implant for treatment of Open Angle Glaucoma or Ocular Hypertension.
Open Angle GlaucomaOcular Hypertension
PolyActiva Pty Ltd6 enrolled1 locationACTRN12621001718831